Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.
Bristow Group (VTOL) shares reacted to news that the company increased the size of its planned private offering of senior secured notes to $500 million. The proceeds are earmarked to refinance 2028 debt and support general corporate purposes.
See our latest analysis for Bristow Group.
The upsized notes offering comes at a time when momentum in Bristow Group’s share price has been firming, with a 30-day share price return of 12.81% and a year-to-date share price return of 9.67%. The 1-year...
If you are wondering whether Alibaba Group Holding's current share price reflects its true value, you are not alone. This article is built to help you frame that question clearly.
The stock last closed at US$170.93, with returns of 10.7% over 7 days, 14.5% over 30 days, 9.8% year to date, 110.8% over 1 year and 54.3% over 3 years. The 5 year return sits at a 30.8% decline.
Recent news around Alibaba has focused on its position as one of China's major e commerce and cloud players, alongside...
Blackline Safety (TSX:BLN) has wrapped up FY 2025 with Q4 revenue of C$39.3 million and a basic EPS loss of C$0.01, while trailing twelve month figures show revenue of C$150.5 million and a basic EPS loss of C$0.10. The company has reported quarterly revenue in a range from C$35.9 million to C$39.3 million over the year, with basic EPS losses between C$0.01 and C$0.04. This points to growing sales alongside persistent but narrowing losses, keeping margins firmly in focus for investors.
See...
If you are wondering whether Arm Holdings' current share price lines up with its real worth, this article is built to walk you through that question step by step.
Despite the hype around chip related names, Arm's share price closed at US$105.11, with returns of a 7% decline over 7 days, a 13.2% decline over 30 days, an 8.4% decline year to date, and a 28.7% decline over 1 year. This may change how investors think about both its growth potential and risk.
Recent attention on Arm has largely...
Automatic Data Processing, Inc. previously declared a regular quarterly dividend of US$1.70 per share, payable on April 1, 2026, to shareholders of record as of March 13, 2026, and authorized a new US$6.00 billion share repurchase program replacing its prior authorization.
This combination of a sizable buyback authorization and continued dividend payments underscores ADP’s emphasis on returning capital to shareholders alongside its recurring-revenue HR and payroll franchise.
We’ll now...
If you are wondering whether Boeing's current share price still offers value after a strong run, this article walks through what the numbers actually say about the stock.
Boeing shares recently closed at US$247.74, with reported returns of 9.0% over the past week, 19.8% over the past month, 8.8% year to date, 46.7% over the past year, 19.6% over three years, and 19.4% over five years.
These moves have unfolded alongside ongoing headlines around the company and the wider aerospace and defense...
In recent days, AngloGold Ashanti has been highlighted by technical analysts for a perfect Technical Rating of 10 and strong setup quality, while benefitting from a broader rally in gold miners supported by robust cash flows and comparatively high dividend yields.
This combination of constructive chart patterns and sector-wide strength in cash generation and payouts is drawing fresh attention to AngloGold Ashanti within the gold mining space.
Next, we’ll examine how this constructive...
Why FormFactor’s recent earnings revisions are drawing attention
FormFactor (FORM) is back on investor watchlists after analysts recently lifted full-year earnings estimates by 18.5%, while the stock has outpaced the broader Computer and Technology sector so far this year.
See our latest analysis for FormFactor.
The upbeat earnings revisions come on top of strong recent momentum, with a 30 day share price return of 34.48% and a 1 year total shareholder return of 74.18%. This suggests...
Protagonist Therapeutics: Recent Move After Strong Multi‑Year Returns
Protagonist Therapeutics (PTGX) has drawn fresh attention after a strong 1 year total return of about 132%, set against more mixed shorter term moves, including a 7% decline over the past month.
See our latest analysis for Protagonist Therapeutics.
At a share price of $84.75, Protagonist Therapeutics has seen some momentum cool in the past month. Its 90 day share price return of 9.35% sits against a very large 3 year total...
In January 2026, MyPoint Credit Union announced it had partnered with Upstart to expand access to personal loans via the Upstart Referral Network, giving qualified Upstart.com applicants tailored MyPoint-branded offers and a streamlined digital application and closing process.
This partnership, alongside rising attention on Upstart’s upcoming fourth-quarter and full-year 2025 results and ongoing credit-risk concerns, is sharpening focus on how its AI lending model balances growth, funding...
In early January 2026, a Montana federal judge allowed a class-action lawsuit over PFAS-laden firefighter turnout gear against 3M, DuPont/Chemours and others to proceed, rejecting multiple motions to dismiss, including RICO-related challenges.
The ruling keeps RICO claims alive pending a Ninth Circuit decision and highlights potentially very large PFAS-related replacement costs for more than one million firefighters’ gear, adding to 3M’s legal and environmental risk profile.
We’ll now...
Earlier this month, CVS Health’s board approved a quarterly dividend of US$0.665 per share, payable on February 2, 2026, to shareholders of record as of January 22, 2026, while the company continues to integrate its retail, insurance, and care-delivery operations.
Beyond capital returns, CVS Health is reinforcing its healthcare platform credentials through initiatives like expanded specialty programs, new coverage for long-acting injectable HIV prevention, and community investments in...
In early January 2026, Bank Hapoalim B.M. completed two US$1.00 billion fixed-rate senior unsecured Eurobond offerings, including 4.722% notes due 2029 and fixed-rate notes due 2032, both priced at 100% of face value.
These twin US-dollar bond issues highlight the bank’s ability to tap international fixed-income markets at scale, potentially enhancing funding flexibility and reinforcing its position in global institutional debt markets.
We’ll now examine how raising US$2.00 billion through...
In January 2026, RWE announced a 50:50 partnership with KKR to develop and operate the Norfolk Vanguard East and West UK offshore wind farms, a roughly 3GW project requiring more than US$15.00 billion in total development and capital expenditure and targeted to supply clean power to over 3 million homes once operational around 2029–2030.
This move deepens KKR’s involvement in large-scale renewable infrastructure, linking its capital to the UK’s push to expand offshore wind capacity as a core...
AIT (TSE:9381) has reported Q3 2026 revenue of ¥15.9 billion and net income of ¥893 million, with basic EPS at ¥38.01, against a backdrop of 12 month earnings growth of 2.7% and a net profit margin of 5.3% over the last year. The company has seen quarterly revenue move from ¥13.5 billion in Q2 2026 and ¥13.7 billion in Q4 2025 to ¥15.9 billion in Q3 2026. EPS shifted from ¥23.84 in Q4 2025 to ¥37.03 in Q1 2026, ¥32.26 in Q2 2026 and ¥38.01 in the latest quarter. This sets up a story where...
If you are wondering whether Unilever's current share price really reflects its long term potential, you are not alone. That is exactly what this article aims to unpack.
Over the short term, Unilever's share price has returned 2.5% over the last 7 days, compared with a 0.3% decline over the last 30 days and a 0.9% decline year to date. The 1 year, 3 year and 5 year returns sit at 2.4%, 21.2% and 22.7% respectively.
Recent attention on Unilever has centered on how its global brands are...
Why STERIS is on investors’ radar today
STERIS (STE) has drawn fresh attention after its recent share move, with the stock closing at $268.26 and posting gains over the past week, month, and past 3 months. Investors are reassessing what the current price implies for future returns.
See our latest analysis for STERIS.
The recent 1-day share price return of 1.52% caps a period of steady gains, with a 30-day share price return of 6.02% and a 1-year total shareholder return of 28.93%. Together,...
